Literature DB >> 24680033

Procedure-based complications to guide informed consent: analysis of society of thoracic surgeons-congenital heart surgery database.

Constantine Mavroudis1, Constantine D Mavroudis2, Jeffrey P Jacobs3, Allison Siegel4, Sara K Pasquali5, Kevin D Hill6, Marshall L Jacobs7.   

Abstract

BACKGROUND: Informed consent refers to the process by which physicians and patients engage in a dialogue to explain and comprehend the nature, alternatives, and risks of a procedure or course of therapy. The goal of this study is to better "inform the process of informed consent" by offering empirically derived procedural complication lists that provide objective contemporary data that surgeons may share with patients and families.
METHODS: The Society of Thoracic Surgeons Congenital Heart Surgery Database was queried for complications for 12 congenital heart operations (2010 to 2011) performed across all Society of Thoracic Surgeons-European Association of Cardio-Thoracic Surgery Congenital Heart Surgery (STAT) risk categories.
RESULTS: The 12 index procedures reviewed for rates of complications were repair of atrial septal defect (ASD), ventricular septal defect (VSD), atrioventricular septal defect (AVSD), tetralogy of Fallot (TOF), coarctation, and truncus arteriosus, as well as arterial switch operation (ASO), ASO-VSD, BiGlenn, Fontan, Norwood procedure, and systemic to pulmonary artery (S-P) shunt. Arrhythmia was the most frequent complication for VSD (5.8%), TOF (8.9%), and AVSD (14.7%) repairs. There was a high rate of sternum left open (planned, unplanned) for ASO (26%, 7%), ASO-VSD (29%, 10%), truncus repair (41%, 11%), and Norwood (63%, 7%). The most frequent complications for other procedures include ASD (unplanned readmission, 1.9%), BiGlenn (chylothorax, 7%), Fontan (pleural effusion, 16%), S-P shunt (reintubation, 10.6%), and coarctation (reintubation, 5.2%).
CONCLUSIONS: The informed consent process for congenital heart surgery may be served by accurate contemporary data on occurrence of complications. While a threshold rate of occurrence of individual complications may guide the physician, rare but important debilitating complications should also be discussed irrespective of frequency. We propose to better inform the process of informed consent by providing objective complications data.
Copyright © 2014 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24680033      PMCID: PMC4276145          DOI: 10.1016/j.athoracsur.2013.12.037

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Prospective survey of factors affecting risk discussion during consent in a surgical specialty.

Authors:  J M Pleat; C S J Dunkin; C E Davies; R M Ripley; M P H Tyler
Journal:  Br J Surg       Date:  2004-10       Impact factor: 6.939

Review 2.  Informed consent, bioethical equipoise, and hypoplastic left heart syndrome.

Authors:  Constantine Mavroudis; Constantine D Mavroudis; Ruth M Farrell; Marshall L Jacobs; Jeffrey P Jacobs; Eric D Kodish
Journal:  Cardiol Young       Date:  2011-12       Impact factor: 1.093

3.  Issues of consent in renal transplantation.

Authors:  A McLaren; G Morris-Stiff; J Casey
Journal:  Ann R Coll Surg Engl       Date:  2001-09       Impact factor: 1.891

4.  An empirically based tool for analyzing mortality associated with congenital heart surgery.

Authors:  Sean M O'Brien; David R Clarke; Jeffrey P Jacobs; Marshall L Jacobs; Francois G Lacour-Gayet; Christian Pizarro; Karl F Welke; Bohdan Maruszewski; Zdzislaw Tobota; Weldon J Miller; Leslie Hamilton; Eric D Peterson; Constantine Mavroudis; Fred H Edwards
Journal:  J Thorac Cardiovasc Surg       Date:  2009-11       Impact factor: 5.209

Review 5.  Beyond informed consent: educating the patient.

Authors:  Lawrence H Brenner; Alison Tytell Brenner; Daniel Horowitz
Journal:  Clin Orthop Relat Res       Date:  2008-12-05       Impact factor: 4.176

6.  An empirically based tool for analyzing morbidity associated with operations for congenital heart disease.

Authors:  Marshall L Jacobs; Sean M O'Brien; Jeffrey P Jacobs; Constantine Mavroudis; Francois Lacour-Gayet; Sara K Pasquali; Karl Welke; Christian Pizarro; Felix Tsai; David R Clarke
Journal:  J Thorac Cardiovasc Surg       Date:  2012-07-24       Impact factor: 5.209

  6 in total
  2 in total

1.  Can a Surgeon Refuse to Operate When an Advance Directive Limits Postoperative Care?

Authors:  Constantine Mavroudis; Jeffrey Gaca; Robert M Sade
Journal:  Ann Thorac Surg       Date:  2016-10       Impact factor: 4.330

2.  Post-operative Chylothorax in Patients with Repaired Transposition of the Great Arteries.

Authors:  Danish Vaiyani; Madhumitha Saravanan; Yoav Dori; Erin Pinto; Matthew J Gillespie; Jonathan J Rome; David J Goldberg; Christopher L Smith; Michael L O'Byrne; Aaron G DeWitt; Chitra Ravishankar
Journal:  Pediatr Cardiol       Date:  2021-11-29       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.